These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071 [TBL] [Abstract][Full Text] [Related]
7. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208 [TBL] [Abstract][Full Text] [Related]
8. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases. Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835 [TBL] [Abstract][Full Text] [Related]
9. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? Schild SE; Behl D; Markovic SN; Brown PD; Sande JR; Deming RL; Rowland KM; Bearden JD Am J Clin Oncol; 2010 Dec; 33(6):633-6. PubMed ID: 20042969 [TBL] [Abstract][Full Text] [Related]
10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685 [TBL] [Abstract][Full Text] [Related]
13. The treatment of brain metastases from malignant melanoma. Douglas JG; Margolin K Semin Oncol; 2002 Oct; 29(5):518-24. PubMed ID: 12407517 [TBL] [Abstract][Full Text] [Related]
14. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. Cohen-Inbar O; Shih HH; Xu Z; Schlesinger D; Sheehan JP J Neurosurg; 2017 Nov; 127(5):1007-1014. PubMed ID: 28059663 [TBL] [Abstract][Full Text] [Related]
15. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity. Diao K; Bian SX; Routman DM; Yu C; Ye JC; Wagle NA; Wong MK; Zada G; Chang EL J Neurooncol; 2018 Sep; 139(2):421-429. PubMed ID: 29696531 [TBL] [Abstract][Full Text] [Related]
17. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade. Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735 [TBL] [Abstract][Full Text] [Related]
18. Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases. Moyers JT; Chong EG; Peng J; Tsai HHC; Sufficool D; Shavlik D; Nagaraj G Cancer Med; 2021 Feb; 10(4):1201-1211. PubMed ID: 33484100 [TBL] [Abstract][Full Text] [Related]
19. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment. Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]